LIVN — LivaNova PLC

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1639691 · United Kingdom
Last close
$91.92
Market Cap
$5.06B
52W High
$99.38
52W Low
$52.37
ADV30
723,153
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 393,148,000 265,051,000 28,425,000 34,294,000 2,713,124,000 563,467,000 1,341,053,000
Jun 2026 390,587,000 273,670,000 49,484,000 108,569,000 2,640,861,000 516,619,000 1,315,539,000
Mar 2026 362,258,000 243,749,000 41,471,000 22,294,000 2,516,351,000 539,706,000 1,305,025,000
Dec 2025 360,921,000 239,773,000 42,578,000 30,906,000 2,606,053,000 635,552,000 1,406,066,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$237,864,000
Investing CF
$-99,865,000
Financing CF
$-216,495,000
CapEx
$-108,847,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$3.00
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-980,564,000
Inventory
$177,881,000
Receivables
$282,647,000
ST Investments
—
EBIT TTM
$154,648,000
Pretax Income TTM
$120,372,000
Interest Exp TTM
$34,276,000
Analysts
11

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,506,914,048
EBITDA
$271,267,008
Free Cash Flow
$67,713,376
Enterprise Value
$4,750,865,920
Total Cash
$563,467,008
Total Debt
$357,071,008
Shares Out
55,086,809
Trailing EPS
$3.49
Book Value
$24.91
ROE
15.5%
ROA
5.1%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,388,053,000 199,390,000 -242,471,000 2,606,053,000 1,406,066,000 1,199,987,000 254,340,000
Dec 2024 1,253,437,000 129,051,000 63,234,000 2,506,389,000 1,186,131,000 1,320,258,000 183,038,000
Dec 2023 1,153,545,000 21,476,000 17,546,000 2,429,563,000 1,151,935,000 1,277,628,000 74,914,000
Dec 2022 1,021,805,000 52,644,000 -86,246,000 2,294,773,000 1,087,149,000 1,207,624,000 69,921,000

TTM Snapshot

Revenues TTM
$1,471,519,000
NetIncome TTM
$188,553,000
OpCashFlow TTM
—
Assets (Latest)
$2,640,861,000
Forward EPS
$4.72

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $95.00 · spot: $94.54 · call volume: 646 · put volume: 263
Expected Move to 2026-12-18: ±$8.22 (8.70%) — implied range $86.32 – $102.77 · ATM straddle on $95.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
MMSI MERIT MEDICAL SYSTEMS INC $5.06B $84.49 —
MMED MiniMed Group, Inc. $5.00B $17.78 —
HAE HAEMONETICS CORP $5.51B $120.92 —
ICUI ICU MEDICAL INC/DE $4.42B $176.91 —
ITGR Integer Holdings Corp $4.32B $126.97 —

News headlines (Yahoo Finance, 1h cache)

Medical costs are crushing insurers—and lifting LivaNova stock
2026-11-18 07:24 · Yahoo
LivaNova Stock Gets Lift From Strong Earnings And Epilepsy Study Results
2026-11-05 04:39 · Yahoo
LivaNova PLC Q3 2026 Earnings Call Summary
2026-11-04 23:07 · Yahoo
LivaNova (LIVN) Q3 2026 Earnings Call Transcript
2026-11-04 18:29 · Yahoo
LivaNova Q3 Earnings Call Highlights
2026-11-04 18:14 · Yahoo
LivaNova (LIVN) Reports Q3 Earnings: What Key Metrics Have to Say
2026-11-04 13:30 · Yahoo
LivaNova (LIVN) Surpasses Q3 Earnings and Revenue Estimates
2026-11-04 11:20 · Yahoo
LivaNova: Q3 Earnings Snapshot
2026-11-04 11:19 · Yahoo
LivaNova Reports Third-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
2026-11-04 11:00 · Yahoo
Neuromodulation Publishes Full 36-Month CORE-VNS Results Demonstrating Sustained and Increasing Benefits of LivaNova’s VNS Therapy for Drug-Resistant Epilepsy
2026-10-23 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.